Center-Based, Home-Based, and Technology-Enhanced Cardiac Rehabilitation Equally Reduce Mortality Risk in Veterans
Abstract Body (Do not enter title and authors here): Introduction: Cardiac rehabilitation (CR) is a class I recommendation following a cardiac event, yet fewer than 20% of eligible patients enroll. Home-based CR (HBCR), especially when enhanced with mobile health tools like fitness trackers and smartphones to increase engagement—termed technology-enabled CR (TECR)—may improve outcomes. We hypothesized that TECR, HBCR (without technology), and center-based CR (CBCR) be associated with lower mortality compared to usual care, with TECR conferring the greatest benefit.
Methods: We studied veterans referred to CR at the Atlanta VA Healthcare System from January 1, 2017, to June 1, 2022. Patients chose TECR, HBCR alone, or CBCR under shared decision-making. Usual care consisted of patients who did not enroll in any CR. Clinical and mortality data were obtained from the VA Corporate Data Warehouse with MDClone, a self-service data analytics platform. We excluded those who died or were lost to follow-up within 30 days of referral and used inverse probability of treatment weighting (IPTW) to balance baseline characteristics.
Results: Among 1,755 referred veterans (mean age 65 [SD 10] years; 50% Black; 6% women), pre-pandemic enrollment before March 16th, 2020, was 15% TECR, 11% HBCR, 33% CBCR, and 41% usual care. Afterwards, HBCR enrollment increased to 30%, CBCR fell to 15%, and others remained stable. After IPTW adjustment, baseline characteristics were well balanced. Over a mean (SD) follow-up of 2.6 (1.5) years, 333 veterans (19%) died. Adjusted hazard ratios for mortality versus usual care were: TECR 0.41 (95% CI, 0.27–0.65), HBCR 0.61 (0.44–0.84), and CBCR 0.56 (0.42–0.73). The TECR estimate was the lowest, but did not significantly differ from HBCR (p=0.14) or CBCR (p=0.21).
Conclusions: All CR formats were associated with lower mortality compared to usual care. Technology-enabled CR may offer additional benefit, but larger randomized trials are needed to determine its comparative effectiveness.
Shah, Amit
( EMORY UNIVERSITY
, Atlanta
, Georgia
, United States
)
Li, Louis
( EMORY UNIVERSITY
, Atlanta
, Georgia
, United States
)
Aggarwal, Vinod
( VHA Office of Healthcare Innovation and Learning, VA Central Office
, Washington
, District of Columbia
, United States
)
Zafari, Abarmard
( EMORY UNIVERSITY
, Atlanta
, Georgia
, United States
)
Park, Linda
( UCSF
, San Francisco
, California
, United States
)
Harzand, Arash
( Atlanta VA Medical Center
, Decatur
, Georgia
, United States
)
Author Disclosures:
Amit Shah:DO NOT have relevant financial relationships
| Louis Li:DO NOT have relevant financial relationships
| Vinod Aggarwal:DO NOT have relevant financial relationships
| Abarmard Zafari:DO NOT have relevant financial relationships
| Linda Park:DO NOT have relevant financial relationships
| Arash Harzand:DO NOT have relevant financial relationships
Jiang Chao, Dong Jianzeng, Cai Jun, Anderson Craig, Du Xin, Tang Yangyang, Han Rong, Song Yanna, Wang Chi, Lin Xiaolei, Yi Yang, Rodgers Anthony, Ma Changsheng